Garde Capital’s Acadia Healthcare ACHC Stock Holding History

Garde Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5	Closed	-$114	–	240
2025 Q2	$114	Hold	5	–	–	﹤0.01%	811
2025 Q1	$152	Buy	+5	New	+$191	﹤0.01%	789

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KCM

Khrom Capital Management Miami Beach, Florida $1.19B AUM 14.29% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Garde Capital's ACHC Position: Q3 2025 in Review

Garde Capital sold out of Acadia Healthcare (ACHC) in Q3 2025, closing a stake of 5 shares — an estimated $114 sold.

Garde Capital first reported a position in ACHC in Q1 2025 and held it in 2 quarters. The position peaked at $152 in Q1 2025. 270 funds tracked by Wall St. Rank hold ACHC as of Q3 2025.

Garde Capital reported no remaining Acadia Healthcare position as of Q3 2025 after selling out during the quarter.
Garde Capital sold 5 Acadia Healthcare shares in Q3 2025, an estimated $114.
Garde Capital first reported a position in Acadia Healthcare in Q1 2025 and held it in 2 quarters.
Garde Capital's Acadia Healthcare position peaked at $152 in Q1 2025.
270 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2025.

Based on Garde Capital's 13F filing for Q3 2025, filed 16 Dec 2025.